The Effect of Sun-like Spectrum With Different Spectrum Composition on Retinal Blood Flow
NCT ID: NCT05594719
Last Updated: 2022-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
75 participants
INTERVENTIONAL
2022-09-06
2022-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Different Outdoor Light Exposure Modes on Retinal Blood Flow
NCT05594732
Red Light Intervention for Myopia Prevention
NCT04825769
Light Emitting Diodes With a Continuous Spectrum of 430-780nm for Myopia Prevention
NCT05728762
Efficacy and Safety of Low-Level Monochromatic Red-Light for High Myopia Control in Adults
NCT05947019
The Effectiveness and Safety of Low-intensity Single-wavelength Red Light in Controlling High Myopia in Children and Adolescents:A Randomized, Controlled, Multicenter Clinical Trial
NCT05184621
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. Sun-like spectrum, color temperature of 5000K, shorter-wavelength dominant;
2. Sun-like spectrum, color temperature of 5000K, wavelength proportion similar to the sunlight;
3. Sun-like spectrum, color temperature of 5000K, longer-wavelength dominant.
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Light group 1
Sun-like spectrum, color temperature of 5000K, shorter-wavelength dominant;
Shorter-wavelength dominant light
Shorter-wavelength dominant light
Light group 2
Sun-like spectrum, color temperature of 5000K, wavelength proportion similar to the sunlight
Light similar to the solar spectrum proportion
Light similar to the solar spectrum proportion with no specific wavelength dominant
Light group 3
Sun-like spectrum, color temperature of 5000K, longer-wavelength dominant.
Shorter-wavelength dominant light
Shorter-wavelength dominant light
Longer-wavelength dominant light
Longer-wavelength dominant light
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Shorter-wavelength dominant light
Shorter-wavelength dominant light
Light similar to the solar spectrum proportion
Light similar to the solar spectrum proportion with no specific wavelength dominant
Longer-wavelength dominant light
Longer-wavelength dominant light
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diopter between -2.0D and 3.0D, and astigmatism not exceed 0.75D;
* No organic disease and in good general condition;
* Have obtained the consent of their parents or guardians, and can cooperate.
Exclusion Criteria
* Other circumstances judged by the investigator to be unsuitable to participate in the research.
7 Years
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Eye Disease Prevention and Treatment Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiangui He, PhD
Role: PRINCIPAL_INVESTIGATOR
Shanghai Eye Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xiangui He
Shanghai, Shanghai Municipality, China
Shanghai Eye Disease Prevention and Treatment Center
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Xiangui He
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Mirhajianmoghadam H, Pina A, Ostrin LA. Objective and Subjective Behavioral Measures in Myopic and Non-Myopic Children During the COVID-19 Pandemic. Transl Vis Sci Technol. 2021 Sep 1;10(11):4. doi: 10.1167/tvst.10.11.4.
Muralidharan AR, Lanca C, Biswas S, Barathi VA, Wan Yu Shermaine L, Seang-Mei S, Milea D, Najjar RP. Light and myopia: from epidemiological studies to neurobiological mechanisms. Ther Adv Ophthalmol. 2021 Dec 19;13:25158414211059246. doi: 10.1177/25158414211059246. eCollection 2021 Jan-Dec.
Rucker F. Monochromatic and white light and the regulation of eye growth. Exp Eye Res. 2019 Jul;184:172-182. doi: 10.1016/j.exer.2019.04.020. Epub 2019 Apr 21.
Baeza Moyano D, González-Lezcano RA. Pandemic of Childhood Myopia. Could New Indoor LED Lighting Be Part of the Solution? Energies. 2021;14(13):3827. doi:10.3390/en14133827
陈军, 陈友三, 王菁菁, et al. 类太阳光谱LED照明对儿童青少年视网膜血流灌注影响的随机对照临床试验. zgxxws. 2022;43(3):338-340. doi:10.16835/j.cnki.1000-9817.2022.03.005
Liu Y, Wang L, Xu Y, Pang Z, Mu G. The influence of the choroid on the onset and development of myopia: from perspectives of choroidal thickness and blood flow. Acta Ophthalmol. 2021 Nov;99(7):730-738. doi: 10.1111/aos.14773. Epub 2021 Feb 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YFZXLDX20220801
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.